Multiple sclerosis and White blood cell count increased
Summary:
White blood cell count increased is found among people with Multiple sclerosis, especially for people who are female, 40-49 old.
The study analyzes which people have White blood cell count increased with Multiple sclerosis. It is created by eHealthMe based on reports of 2,591 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2,591 people who have Multiple Sclerosis and White Blood Cell Count Increased are studied.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 2,109 drugs and 1,306 conditions by eHealthMe.
What is White blood cell count increased?
White blood cell count increased is found to be associated with 2,824 drugs and 2,504 conditions by eHealthMe.
Number of White blood cell count increased in Multiple sclerosis reports submitted per year:
Gender of people who have Multiple sclerosis and experienced White blood cell count increased *:
Age of people who have Multiple sclerosis and experienced White blood cell count increased *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have White blood cell count increased?
Check whether White blood cell count increased is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Related studies
Treatments, associated drugs and conditions:
- Multiple sclerosis (734,929 reports)
- White blood cell count increased (50,251 reports)
COVID vaccines that are related to White blood cell count increased:
- White blood cell count increased in Moderna COVID Vaccine
- White blood cell count increased in Pfizer BioNTech Covid Vaccine
- White blood cell count increased in Johnson and Johnson Covid Vaccine
Common drugs associated with White blood cell count increased:
- Clozaril: 4,841 reports
- Prednisone: 3,358 reports
- Aspirin: 2,577 reports
- Humira: 2,237 reports
- Omeprazole: 1,769 reports
- Methotrexate: 1,661 reports
- Metformin: 1,541 reports
- Furosemide: 1,536 reports
- Jakafi: 1,512 reports
- Lasix: 1,432 reports
All the drugs that are associated with White blood cell count increased:
- White blood cell count increased (2,824 drugs)
Common conditions associated with White blood cell count increased:
- Schizophrenia: 4,175 reports
- Multiple sclerosis: 2,591 reports
- High blood pressure: 2,397 reports
- Rheumatoid arthritis: 2,224 reports
- Primary myelofibrosis: 1,526 reports
- Depression: 1,524 reports
All the conditions that are associated with White blood cell count increased:
- White blood cell count increased (2,504 conditions)
How the study uses the data?
The study is based on White blood cell count increased and Multiple sclerosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Heparin Sodium and Appetite - Increased - 12 seconds ago
- Advair Diskus 100/50 and Pain In Jaw - 12 seconds ago
- Protonix and Prozac drug interaction - 33 seconds ago
- Norethindrone Acetate and Thinking Abnormal - 48 seconds ago
- Cymbalta and Dysfunctional Uterine Bleeding (Dub) - 54 seconds ago
- Remodulin and Incontinence - a minute ago
- Peg-Intron and Zolpidem Tartrate drug interaction - a minute ago
- Macrobid and Lung Infection - a minute ago
- Remifentanil Hydrochloride and Haemolytic Anaemia - a minute ago
- Tamoxifen Citrate and Indigestion - a minute ago